Foot Process Effacement Is an Early Marker of Nephropathy in Young Classic Fabry Patients without Albuminuria | Zendy

Camilla Tøndel | Zendy; Takahiro Kanai | Zendy; Kristin Kampevold Larsen | Zendy; Shuichi Ito | Zendy; Juan Politei | Zendy; David G. Warnock | Zendy; Einar Svarstad | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Foot Process Effacement Is an Early Marker of Nephropathy in Young Classic Fabry Patients without Albuminuria

Author(s) -

Camilla Tøndel,

Takahiro Kanai,

Kristin Kampevold Larsen,

Shuichi Ito,

Juan Politei,

David G. Warnock,

Einar Svarstad

Publication year - 2014

Publication title -

the nephron journals/nephron journals

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.951

H-Index - 72

eISSN - 2235-3186

pISSN - 1660-8151

DOI - 10.1159/000369309

Subject(s) - medicine , podocyte , enzyme replacement therapy , fabry disease , urology , biopsy , kidney disease , nephropathy , kidney , gastroenterology , endocrinology , surgery , proteinuria , disease , diabetes mellitus

In Fabry disease, globotriaocylceramid (GL3) starts to accumulate in kidney cells in utero, and continues to accumulate throughout childhood and adulthood with progressive tissue damage, which may lead to renal failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research